EFFICACY OF UPADACITINIB ON LUMINAL STENOSIS IN PATIENTS WITH MODERATELY TO SEVERELY ACTIVE CROHN’S DISEASE: A POST HOC ANALYSIS OF PHASE 3 STUDIES

Walter Reinisch  ¹     Raja Atreya  ²     Vipul Jairath  ^{3, 4}     Julian Panés  ⁵     Edward V. Loftus  ⁶     Shuhei Hosomi  ⁷     Maria T. Abreu  ⁸     Florian Rieder  ⁹     Valencia Remple  ¹⁰     Elena Marced     Elena Dubcenco     Samuel Anyanwu     Andrew Garrison     Jean-Frédéric Colombel  ^11    
1 Medical University of Vienna, Vienna, Austria
² Friedrich-Alexander-University Erlangen-Nürnberg, Erlangen, Germany
³ Western University, London, Canada
⁴ Alimentiv, London, Canada
⁵ Hospital Clínic Barcelona, Barcelona, Spain
⁶ Mayo Clinic School of Medicine and Science, Rochester, United States
⁷ Osaka Metropolitan University Graduate School of Medicine, Osaka, Japan
⁸ University of Miami Miller School of Medicine, Miami, United States
⁹ Cleveland Clinic Foundation, Cleveland, United States
¹⁰ AbbVie Inc., North Chicago, United States
¹¹ Icahn School of Medicine at Mount Sinai, New York, United States

Topic
IBD

Session
Medical therapy of IBD: Facts and challenges (Posters)

Conference
UEG Week 2023

Citation
United European Gastroenterology Journal 2023; 11 (Supplement 8)